国际医院感染控制联盟（INICC）报告（2003-2008年）翻译有奖
本帖最后由 潮水 于 2010-2-22 13:00 编辑美国医院感染控制杂志2010年第2期
International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009
American Journal of Infection Control
Volume 38, Issue 2, March 2010, Pages 95-104.e2
We report the results of the International Infection Control Consortium (INICC) surveillance study from January 2003 through December 2008 in 173 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study, using Centers for Disease Control and Prevention (CDC) US National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system ) definitions for device-associated health care-associated infection, we collected prospective data from 155,358 patients hospitalized in the consortium's hospital ICUs for an aggregate of 923,624 days. Although device utilization in the developing countries' ICUs was remarkably similar to that reported from US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection were markedly higher in the ICUs of the INICC hospitals: the pooled rate of central venous catheter (CVC)-associated bloodstream infections (BSI) in the INICC ICUs, 7.6 per 1000 CVC-days, is nearly 3-fold higher than the 2.0 per 1000 CVC-days reported from comparable US ICUs, and the overall rate of ventilator-associated pneumonia (VAP) was also far higher, 13.6 versus 3.3 per 1000 ventilator-days, respectively, as was the rate of catheter-associated urinary tract infection (CAUTI), 6.3 versus 3.3 per 1000 catheter-days, respectively. Most strikingly, the frequencies of resistance of Staphylococcus aureus isolates to methicillin (MRSA) (84.1% vs 56.8%, respectively), Klebsiella pneumoniae to ceftazidime or ceftriaxone (76.1% vs 27.1%, respectively), Acinetobacter baumannii to imipenem (46.3% vs 29.2%, respectively), and Pseudomonas aeruginosa to piperacillin (78.0% vs 20.2%, respectively) were also far higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 23.6% (CVC-associated bloodstream infections) to 29.3% (VAP).
Key Words: Hospital infection; nosocomial infection; health care-associated infection; INICC; International Nosocomial Infection Consortium; device-associated infection; antibiotic resistance; ventilator-associated pneumonia; catheter-associated urinary tract infection; central line-associated bloodstream infections; bloodstream infection; urinary tract infection; developing countries; limited resources countries; low income countries; network 期待翻译，值得学习........ 美国感染控制杂志，2010年3月第38卷第2期95-104
我们报告了国际医院感染控制联盟于2003年1月到2008年12月在拉丁美洲、亚洲、非洲和欧洲的173个重症监护病房（ICU）的监测结果。使用美国疾病预防控制中心(CDC)
明天接着翻译 这是不是摘要全文哪里去找是PubMed吗我没找到可否给链接一下？{:1_8:} 回复 4# 手榴弹
没有全文，但如果需要可以索取！ 国际医院感染控制联盟(INICC)报告, 2003-2008数据概要
美国医院感染控制杂志2010年第2期
我们在此通报国际感染控制联合会（INICC）从2003年1月至2008年12在拉丁美洲，亚洲，非洲和欧洲173处ICU（加护病房）的监测研究结果。在6年的研究中，我们利用疾病控制和预防中心（CDC）美国国家医疗安全网（NHSN，原全国医院感染监控系统）关于导管相关感染及院内感染的记录，从上述医院ICU收治的155358例患者总计923624天住院情况中收集了预期数据。根据美国CDC NHSN网的记录，虽然发展中国家的ICU使用导管的情况与美国ICU非常相似，但INICC所监测的医院中ICU导管相关医院感染的报道明显要高：在INICC监测的ICU里中心静脉置管相关（CVC）血液感染(BSI)抽样数据为7.6人次/每1000 中心静脉置管天数，美国类似ICU的数据为2.0人次/每1000中心静脉置管天数，前者是后者数据的近3倍，而呼吸机相关性肺炎（VAP）每1000天发生率为13.6比3.3，而导管相关性尿路感染（CAUTI）每1000天的发生率为6.3比3.3。更惊人的是，耐药菌株出现的频率此次监测的医院也远远高于美国同水平ICU：如耐甲氧西林金黄色葡萄球菌（MRSA）（分别为84.1％比56.8％），耐头孢他啶或头孢曲松肺炎克雷伯菌（分别为76.1％比27.1％），耐亚胺培南鲍曼不动杆菌（分别为46.3％比29.2％），和耐哌拉西林铜绿假单胞菌（分别为78.0％比20.2％），未经修正的导管相关性感染导致的超额死亡率粗略统计也在23.6％（CVC的相关血液感染）到29.3％（VAP）不等。关键词：医院感染，院内感染，卫生保健相关感染; INICC，国际医院感染联合会;导管相关感染，抗生素耐药性;呼吸机相关性肺炎，导管相关尿路感染; 中心静脉置管相关血液感染;
血液感染;尿路感染，发展中国家，资源有限的国家;低收入国家;网络
翻译的不对的，大家拍砖头，哈～
页:
[1]